StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.60+0.00 (0.00%)

Close on Nov 17, 2026Market cap $148.68MP/E –Yield –

Abeona Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Abeona Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 13.0×, with a median of 2.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.0×−0.6
2025Dec 31, 20251.6×−3.7
2024Dec 31, 20245.3×−0.3
2023Dec 29, 20235.6×+3.7
2022Dec 30, 20221.9×+1.5
2021Dec 31, 20210.4×−0.7
2020Dec 31, 20201.2×−0.6
2019Dec 31, 20191.7×−0.5
2018Dec 31, 20182.2×−4.8
2017Dec 29, 20177.0×+4.5
2016Dec 30, 20162.5×–

More Abeona Therapeutics figures

See a number that looks wrong?